Genetic Contribution to Metastatic Prostate Cancer

This article reviews key literature on individual genes, recognizing BRCA2 as the gene most commonly altered in the metastatic setting. This article discusses the importance of representative and diverse inclusion, and efforts to advance management for at-risk carrier populations to maximize clinical benefit.PMID:34210490 | DOI:10.1016/j.ucl.2021.03.005

Source: The Urologic Clinics of North America - July 2, 2021 Category: Urology & Nephrology Authors: Alexandra O Sokolova Elias I Obeid Heather H Cheng Source Type: research